Skip to content
Steady
Get Steady
ResearchSide effects
Side effectsSafetyWegovy

Gallbladder risk on a GLP-1: what to watch for, and what protects you

Fast weight loss is the biggest single risk factor for gallstones. GLP-1s deliver fast weight loss. Here is what the data shows about the actual risk, and the small things that lower it.

Published May 20, 20265 min read
3 primary sources citedReviewed by Steady editorial team

The 30-second summary

  • GLP-1 medications carry a small but real increase in gallbladder problems, gallstones and acute cholecystitis, compared with placebo or other weight-loss approaches.
  • The biggest driver is rate of weight loss, not the drug itself. Anyone losing weight rapidly has higher gallstone risk.
  • Severe right-upper-abdominal pain, fever, or yellow eyes: these are emergencies. Don't wait. The risk of a serious gallbladder event is the reason the warning exists.

What the research actually shows

A 2022 meta-analysis in JAMA Internal Medicine pooled 76 randomised trials of GLP-1 receptor agonists (Liu et al.). The headline number: about 27 additional gallbladder events per 10,000 person-years in people taking GLP-1s compared with placebo or active comparators. The effect was larger in:

  • Higher doses
  • Longer treatment duration
  • People taking the drug for weight loss (not diabetes), where the rate of loss is faster

The absolute risk is still small. The relative risk is meaningful enough that the FDA labels mention it explicitly. (Liu et al., JAMA Intern Med 2022.)

Why it happens

Two mechanisms, both plausible:

  1. Rapid weight loss changes the cholesterol composition of bile. When you lose weight fast, your liver dumps more cholesterol into bile than the bile can keep dissolved. Cholesterol precipitates. Cholesterol stones form. This is the same mechanism that causes gallstones after bariatric surgery, after very-low-calorie diets, and during any aggressive weight-loss intervention.
  2. GLP-1s slow gallbladder contraction. Bile stagnates in the gallbladder longer between meals. Stagnant bile is more likely to form sludge and stones.

The first mechanism is dose-of-weight-loss-dependent. The second is dose-of-drug-dependent. Both are amplified at the highest GLP-1 doses.

Who is most at risk

Risk factors that stack with GLP-1 use:

  • Previously known gallstones (even if asymptomatic)
  • Female sex (already 2–3× male baseline risk)
  • Pregnancy, recent or past
  • Age over 40
  • Family history of gallstones
  • Type-2 diabetes
  • Rapid weight loss (over 1% per week)
  • Higher dose GLP-1
  • Hispanic or Native American ethnicity (genetics matters here)

A woman in her late 40s losing 1.5% per week on the maximum dose of tirzepatide is in the higher-risk bracket. A woman in her 30s losing 0.6% per week on a moderate semaglutide dose is in the lower-risk bracket.

What protects you

  1. Slow the weight loss. Aim for 0.5–1% per week, not faster. If the scale is dropping faster, talk to your prescriber about pausing your titration. (See our plateau article for the math.)
  2. Eat enough fat in your meals, regularly. Counterintuitive, but real. Fat in a meal triggers the gallbladder to contract and empty. A meal with almost no fat lets bile sit. The protein-and-veggies meals women on GLP-1s tend to gravitate toward can be very low in fat. A tablespoon of olive oil, half an avocado, some salmon, these are not optional.
  3. Eat consistently. Long gaps between meals (over 12 hours, repeatedly) increase gallbladder stagnation. GLP-1s blunt hunger to the point where some women skip breakfast and skip lunch. The body does not thank you for it.
  4. Stay hydrated. Bile is mostly water. Dehydration concentrates it.
  5. Ask about ursodeoxycholic acid (UDCA) if your risk is high. This is a bile salt that has been shown in surgical and very-low-calorie-diet populations to prevent gallstones during rapid weight loss. It is not standard prophylaxis on GLP-1s, but it has been used. This is a prescriber's decision, not a self-treatment.

The symptoms that need an emergency visit

Severe gallbladder problems present with specific, recognizable symptoms. Memorise these.

  • Severe pain in the right upper abdomen, often radiating to the right shoulder blade or back
  • Pain that comes on after a meal, especially a fatty one, and lasts more than 30 minutes
  • Nausea and vomiting alongside the pain (this can be confusing, both are possible side effects of the drug itself, but the pain pattern is the key signal)
  • Fever or chills
  • Yellowing of the skin or whites of the eyes (jaundice)
  • Dark urine, pale stools

If you have severe right-upper-abdominal pain, do not wait until tomorrow to see if it passes. Go to the emergency department. Acute cholecystitis can progress to bile-duct obstruction, pancreatitis, or sepsis, and the right action is hours, not days.

What happens if you have a gallbladder attack on a GLP-1

The standard treatment for symptomatic gallstones is laparoscopic cholecystectomy, removal of the gallbladder. The surgery is common and generally low-risk. After surgery, most women can resume a GLP-1, though many prescribers pause it for 2–4 weeks during recovery.

You can live a long, healthy life without a gallbladder. The bile that was stored in it now drips continuously into the small intestine. Some women experience looser stools after fatty meals for a few months afterwards; most adjust without much trouble.

What Steady does with this

If you log severe abdominal pain in the symptoms category, the coach is built to flag the gallbladder warning and recommend immediate medical attention. The same goes for jaundice, fever with pain, or a combination of GI symptoms that fit the cholecystitis pattern. This is not diagnostic, it is a prompt to stop chatting with an app and call your doctor.

Sources

  1. Liu L et al. Association of GLP-1 RA Use with Risk of Gallbladder and Biliary Diseases. JAMA Intern Med 2022. JAMA
  2. FDA Prescribing Information, Wegovy. Section 5.4, Acute Gallbladder Disease. Label
  3. Erlinger S. Gallstones in obesity and weight reduction. Eur J Gastroenterol Hepatol 2000. PubMed

Medical disclaimer: Severe abdominal pain is an emergency, not a question for an app. See our full medical disclaimer.

Reviewed by Steady editorial team.
Last updated 2026-05-20.
Keep reading